Sin conexión a internet: se muestra la versión guardada de la página.

Adicet Bio Inc

USUSD
← Al Screener

Adicet Bio Inc (LSE:0HX7) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
adicetbio.com
Relaciones con los Inversores
adicetbio.com/investors/
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede Central
BOSTON, United States
Consejero Delegado
Chen Schor
Empleados
102
Cotiza Desde
08.01.2021 (LSE:0HX7)
Acciones en Circulación
9.36 M a 2026-08-03
Capital Flotante
7.43 M
Capitalización Bursátil
52.52 M USD
Insiders
1.08%
Inversores Institucionales
64.72%
Industria (SIC)
Pharmaceutical Preparations
FCF
−85.0 M USD
Deuda
0
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
Descripción

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksACET principalUSD5.74 -7.12%acciones ordinarias
LSE London Stock Exchange0HX7 IOBUSD6.51 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo
anuncio

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
RA Capital Management, L…9.96%932 6242026-06-30
Orbimed Advisors LLC.9.02%844 7872026-06-30
Franklin Resources, Inc.6.69%626 5712026-06-30
Citadel Advisors Llc4.62%432 7382026-06-30
Vanguard Capital Managem…3.67%343 2282026-06-30
Adage Capital Partners G…2.93%274 3752026-06-30
Renaissance Technologies…2.84%265 9452026-06-30
Stonepine Capital Manage…2.62%245 5182026-06-30
VANGUARD INDEX FUNDS-Van…2.57%240 9462026-06-30
Franklin Strategic Serie…2.41%225 1862026-07-31
Alyeska Investment Group…2.18%203 7992026-06-30
Schonfeld Strategic Advi…2.09%195 5142026-06-30
KLICKSTEIN LLOYD (Direct…≈1.16%108 5662025-06-11
VANGUARD INDEX FUNDS-Van…1.06%98 9122026-06-30
Bridgeway Funds, Inc.-Ul…0.92%85 9592026-06-30
Fidelity Concord Street…0.45%42 1112026-07-31
iShares Trust-iShares Mi…0.25%23 7812026-08-31
DUBIN STEVE (Director)≈0.24%22 7002025-06-11
Fidelity Concord Street…0.19%17 3492026-07-31
CHODAKEWITZ JEFFREY A. M…≈0.19%17 7002025-06-11
SINCLAIR ANDREW (Directo…≈0.19%17 7002025-06-11
Dimensional ETF Trust-Di…0.16%14 5202026-07-31
DFA INVESTMENT DIMENSION…0.15%14 2642026-07-31
Fidelity Concord Street…0.13%12 3612026-07-31
PENG KATIE (Director)≈0.13%11 8002025-06-11
ORBIMED ADVISORS, L.L.C.…——2026-04-08